Journal article
Role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice
OM Dean, M van den Buuse, AI Bush, DL Copolov, F Ng, S Dodd, M Berk
Current Medicinal Chemistry | Published : 2009
Abstract
The tripeptide, glutathione (γ-glutamylcysteinylglycine) is the primary endogenous free radical scavenger in the human body. When glutathione (GSH) levels are reduced there is an increased potential for cellular oxidative stress, characterised by an increase and accruement of reactive oxygen species (ROS). Oxidative stress has been implicated in the pathology of schizophrenia and bipolar disorder. This could partly be caused by alterations in dopaminergic and glutamatergic activity that are implicated in these illnesses. Glutamate and dopamine are highly redox reactive molecules and produce ROS during normal neurotransmission. Alterations to these neurotransmitter pathways may therefore incr..
View full abstractGrants
Funding Acknowledgements
This study was supported by a research scholarship provided by the National Health and Medical Research Council (to O. M. D) and Operational Infrastructure Support (OIS) from the Victorian State Government.